Results for "Metformin TAME Trial" in Diabetes

20 articles

Metformin Shows Promise for Better Surgical Recovery in Older Adults
Metabolic Health

Metformin Shows Promise for Better Surgical Recovery in Older Adults

Clinical trial tested whether metformin could improve surgical outcomes and reduce hospital stays in non-diabetic older patients.

Clinical Trial
Mar 28, 2026 1
Metformin Shows Promise for Preventing Frailty in Older Adults
Metabolic Health

Metformin Shows Promise for Preventing Frailty in Older Adults

Major trial tests whether diabetes drug metformin can prevent frailty syndrome that affects millions of aging adults.

Clinical Trial
Mar 28, 2026 1
Metformin Shows Promise for Protecting Memory in Early Cognitive Decline
Metabolic Health

Metformin Shows Promise for Protecting Memory in Early Cognitive Decline

Columbia University tested whether the diabetes drug metformin could slow memory loss in people with mild cognitive impairment.

Clinical Trial
Mar 29, 2026 1
Metformin Shows Promise for Healthy Aging in Non-Diabetic Adults
Metabolic Health

Metformin Shows Promise for Healthy Aging in Non-Diabetic Adults

Wake Forest study explores whether the diabetes drug metformin can trigger cellular changes linked to longevity in healthy people.

Clinical Trial
Mar 28, 2026 1
Metformin Plus Strength Training Shows Promise for Muscle Building in Seniors
Metabolic Health

Metformin Plus Strength Training Shows Promise for Muscle Building in Seniors

Clinical trial tested whether metformin could enhance resistance training benefits for muscle mass and strength in older adults.

Clinical Trial
Mar 28, 2026 1
Metformin Shows Promise for Improving Blood Vessel Health in Metabolic Syndrome
Metabolic Health

Metformin Shows Promise for Improving Blood Vessel Health in Metabolic Syndrome

Four-year study examined whether metformin could protect blood vessels in people with metabolic syndrome beyond its diabetes benefits.

Clinical Trial
Mar 28, 2026 1
Metformin Study Explores Insulin-Testosterone Link in Postmenopausal Women
Metabolic Health

Metformin Study Explores Insulin-Testosterone Link in Postmenopausal Women

University of Pennsylvania researchers investigated how insulin resistance and testosterone interact in women after menopause.

Clinical Trial
Mar 28, 2026 1
Metformin Shows Promise for Boosting Vaccine Response in Older Adults
Metabolic Health

Metformin Shows Promise for Boosting Vaccine Response in Older Adults

Small trial tested whether the diabetes drug metformin could enhance immune response to pneumonia vaccine in aging adults.

Clinical Trial
Mar 28, 2026 1
Metformin May Help or Harm Aging Based on Your Insulin Sensitivity
Metabolic Health

Metformin May Help or Harm Aging Based on Your Insulin Sensitivity

New study reveals metformin's anti-aging effects depend entirely on whether you're insulin resistant or sensitive.

Clinical Trial
Mar 28, 2026 1
CT-868 Dual Agonist Targets Blood Sugar and Obesity in Phase 2 Diabetes Trial
Metabolic Health

CT-868 Dual Agonist Targets Blood Sugar and Obesity in Phase 2 Diabetes Trial

Carmot Therapeutics tests CT-868, a novel dual incretin receptor agonist, for HbA1c reduction in overweight and obese adults with poorly controlled T2DM.

Clinical Trial
Jun 16, 2026 0
Metformin May Boost Flu Vaccine Response in Older Adults
Metabolic Health

Metformin May Boost Flu Vaccine Response in Older Adults

Small trial tests whether diabetes drug metformin can enhance immune response to flu vaccination in aging adults.

Clinical Trial
Mar 29, 2026 2
Diet, Exercise and Metformin Combination Shows Promise for Reversing Frailty in Seniors
Metabolic Health

Diet, Exercise and Metformin Combination Shows Promise for Reversing Frailty in Seniors

VA study tests whether combining lifestyle changes with metformin can reverse muscle loss and frailty in obese older adults.

Clinical Trial
Mar 28, 2026 1
Diabetes Drug Pioglitazone Shows Promise for Reversing Fatty Liver Disease
Metabolic Health

Diabetes Drug Pioglitazone Shows Promise for Reversing Fatty Liver Disease

176-person trial tested whether pioglitazone could improve liver health by targeting insulin resistance in patients with fatty liver disease.

Clinical Trial
Mar 29, 2026 2
Small-Sided Football Games Tested as Hybrid Exercise Therapy for Type 2 Diabetes
Metabolic Health

Small-Sided Football Games Tested as Hybrid Exercise Therapy for Type 2 Diabetes

A completed RCT tests whether small-sided football sessions 3x/week improve glucose control and metabolic health in T2DM patients on GLP-1 and SGLT2 drugs.

Clinical Trial
Jun 14, 2026 0
Triple Therapy Targets Diabetes and Muscle Loss in Elderly Adults
Metabolic Health

Triple Therapy Targets Diabetes and Muscle Loss in Elderly Adults

Mediterranean diet, resistance training, and diabetes medication combined to combat sarcopenia and improve metabolic health in older adults.

Clinical Trial
Mar 28, 2026 1
Landmark Study Shows Lifestyle Changes Cut Diabetes Risk by 58% in High-Risk Adults
Metabolic Health

Landmark Study Shows Lifestyle Changes Cut Diabetes Risk by 58% in High-Risk Adults

Major prevention trial proves diet and exercise dramatically reduce diabetes onset compared to medication alone.

Clinical Trial
Mar 29, 2026 7
Intensive Diabetes Control Study Shows Mixed Results for Heart Disease Prevention
Metabolic Health

Intensive Diabetes Control Study Shows Mixed Results for Heart Disease Prevention

Major trial of 10,251 diabetics reveals surprising outcomes from aggressive blood sugar, blood pressure, and cholesterol management.

Clinical Trial
Mar 28, 2026 8
New Drug GFT505 Shows Promise for Fatty Liver Disease in Phase IIb Trial
Metabolic Health

New Drug GFT505 Shows Promise for Fatty Liver Disease in Phase IIb Trial

275-patient study tests novel liver-targeted therapy for NASH, a serious form of fatty liver disease affecting millions worldwide.

Clinical Trial
Mar 28, 2026 2
Takeda Tests TAK-510 Safety in First Human Trial for Nausea and Vomiting
Metabolic Health

Takeda Tests TAK-510 Safety in First Human Trial for Nausea and Vomiting

Takeda's Phase 1 trial evaluates the safety and tolerability of TAK-510, a novel injectable agent targeting nausea and vomiting, across escalating doses.

Clinical Trial
Jun 12, 2026 0
Mediterranean Diet Plus Intermittent Fasting Shows Promise for Reversing Type 2 Diabetes
Metabolic Health

Mediterranean Diet Plus Intermittent Fasting Shows Promise for Reversing Type 2 Diabetes

Small study tests whether combining Mediterranean eating, intermittent fasting, and exercise can reverse diabetes in 6 months.

Clinical Trial
Mar 28, 2026 2
Page 1 of 2Next